Literature DB >> 22175283

Assessment of appropriateness of screening community-dwelling older people to prevent functional decline.

Yvonne M Drewes1, Jacobijn Gussekloo, Victor van der Meer, Henk Rigter, Janny H Dekker, Marleen J B M Goumans, Job F M Metsemakers, Riki van Overbeek, Sophia E de Rooij, Henk J Schers, Marieke J Schuurmans, Ferd Sturmans, Kerst de Vries, Rudi G J Westendorp, Annet W Wind, Willem J J Assendelft.   

Abstract

OBJECTIVES: To identify appropriate screening conditions, stratified according to age and vulnerability, to prevent functional decline in older people.
DESIGN: A RAND/University of California at Los Angeles appropriateness method.
SETTING: The Netherlands. PARTICIPANTS: A multidisciplinary panel of 11 experts. MEASUREMENTS: The panelists assessed the appropriateness of screening for 29 conditions mentioned in guidelines from four countries, stratified according to age (60-74, 75-84, ≥85) and health status (general, vital, and vulnerable) and received a literature overview for each condition, including the guidelines and up-to-date literature. After an individual rating round, panelists discussed disagreements and performed a second individual rating. The median of the second ratings defined the appropriateness of screening.
RESULTS: The panel rated screening to be appropriate in three of the 29 conditions, indicating that screening was expected to prevent functional decline. Screening for insufficient physical activity was considered appropriate for all three age and health groups. Screening for cardiovascular risk factors and smoking was considered appropriate for the general and vital population aged 60 to 74. Of the 261 ratings, 63 (24%) were classified as uncertain, of which 42 (67%) concerned the vulnerable population. The panelists considered conditions inappropriate mainly because of lack of an adequate screening tool or lack of evidence of effective interventions for positive screened persons.
CONCLUSION: The expert panel considered screening older people to prevent functional decline appropriate for insufficient physical activity and smoking and cardiovascular risk in specific groups. For other conditions, sufficient evidence does not support screening. Based on their experience, panelists expected benefit from developing tests and interventions, especially for vulnerable older people.
© 2011, Copyright the Authors Journal compilation © 2011, The American Geriatrics Society.

Entities:  

Mesh:

Year:  2011        PMID: 22175283     DOI: 10.1111/j.1532-5415.2011.03775.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  5 in total

1.  [Profiling of patients in a specialized geriatric outpatient clinic].

Authors:  Jörg Martin Rohde; Asha Kunnel; Ingrid Becker; Heinz L Unger; Jana Hummel; Gabriele Röhrig-Herzog
Journal:  Z Gerontol Geriatr       Date:  2022-05-06       Impact factor: 1.281

2.  GPs' perspectives on preventive care for older people: a focus group study.

Authors:  Yvonne M Drewes; Julia M Koenen; Wouter de Ruijter; D J Annemarie van Dijk-van Dijk; Gerda M van der Weele; Barend J C Middelkoop; Ria Reis; Willem J J Assendelft; Jacobijn Gussekloo
Journal:  Br J Gen Pract       Date:  2012-11       Impact factor: 5.386

3.  Variability in vulnerability assessment of older people by individual general practitioners: a cross-sectional study.

Authors:  Yvonne M Drewes; Jeanet W Blom; Willem J J Assendelft; Theo Stijnen; Wendy P J den Elzen; Jacobijn Gussekloo
Journal:  PLoS One       Date:  2014-11-07       Impact factor: 3.240

4.  Favourable outcomes of a preventive screening and counselling programme for older people in underprivileged areas in the Netherlands: The PRIMUS project.

Authors:  D J Annemarie van Dijk; Matty R Crone; Pepijn van Empelen; Willem J Assendelft; Barend J Middelkoop
Journal:  Prev Med Rep       Date:  2017-03-22

5.  Assessment of the appropriateness of cardiovascular preventive medication in older people: using the RAND/UCLA Appropriateness Method.

Authors:  Milly A van der Ploeg; Rosalinde K E Poortvliet; Wilco P Achterberg; Simon P Mooijaart; Jacobijn Gussekloo; Yvonne M Drewes
Journal:  BMC Geriatr       Date:  2022-05-05       Impact factor: 4.070

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.